New collagen injection aims to smooth wrinkles and plump skin
NCT ID NCT07413445
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early trial tests an injectable collagen-based product called MEC REGENERATE® in 20 adults aged 35–65 with skin laxity, mid-face volume loss, or wrinkles. Participants receive a single injection session, and researchers check safety and skin hydration after 60 days. The goal is to see if the product is safe and may improve skin appearance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Injectable recombinant collagen-based product
- What this could lead to
- If it works, this could point toward a non-surgical option to temporarily improve skin hydration and reduce wrinkles.
- What could go wrong
- This is a very small, early study with only 20 people and no control group. Results may not apply to the general population, and long-term safety or effectiveness is unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LAXITY; SKIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ospedale Policlinico San Martino, Istituto di Ricovero e Cura a Carattere Scientifico
Genova, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Collagen-Boosting injection tighten loose neck skin?
- Laser vs. ultrasound: which zaps Crow's feet best?
- Botox vs. xeomin: which smooths wrinkles better?
- Acupuncture needles vs. wrinkles: one session may boost skin thickness
- Ultrasound eyebrow lift shows promise in clinical trial
- Can a new serum tighten skin for women on ozempic?